|
1
|
Huang YQ, Ma X, Wang J, et al: Therapeutic
efficacy and safety of Paeoniae Radix Rubra formulae in relieving
hyperbilirubinemia induced by viral hepatitis: A meta-analysis.
Front Pharmacol. 7:632016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang R, Xiong AZ, Teng ZQ, Yang QW, Shi YH
and Yang L: Radix Paeoniae Rubra and Radix Paeoniae Alba attenuate
CCl4-induced acute liver injury: An ultra-performance liquid
chromatography-mass spectrometry (UPLC-MS) based metabolomic
approach for the pharmacodynamic study of Traditional Chinese
Medicines (TCMs). Int J Mol Sci. 13:14634–14647. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin MY, Lee YR, Chiang SY, Li YZ, Chen YS,
Hsu CD and Liu YW: Cortex Moutan induces bladder cancer cell death
via apoptosis and retards tumor growth in mouse bladders. Evid
Based Complement Alternat Med. 2013:2072792013.PubMed/NCBI
|
|
4
|
He DY and Dai SM: Anti-inflammatory and
immunomodulatory effects of paeonia lactiflora pall., a traditional
chinese herbal medicine. Front Pharmacol. 2:102011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deng H, Yan C, Xiao T, Yuan D and Xu J:
Total glucosides of Paeonia lactiflora Pall inhibit vascular
endothelial growth factor-induced angiogenesis. J Ethnopharmacol.
127:781–785. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Chen CX and Shen YH: Effects of
total glucosides from paeony (Paeonia lactiflora Pall) roots
on experimental atherosclerosis in rats. J Ethnopharmacol.
135:469–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Q, Yang L, Xiong A, Lu L, Wang R and
Wang Z: Metabolomics study of anti-inflammatory action of Radix
Paeoniae Rubra and Radix Paeoniae Alba by ultraperformance liquid
chromatography-mass spectrometry. Zhongguo Zhong Yao Za Zhi.
36:694–697. 2011.(In Chinese). PubMed/NCBI
|
|
8
|
Juan YC, Chang CC, Tsai WJ, Lin YL, Hsu YS
and Liu HK: Pharmacological evaluation of insulin mimetic novel
suppressors of PEPCK gene transcription from Paeoniae Rubra Radix.
J Ethnopharmacol. 137:592–600. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu W, Zhong W, Liu J, Liu H and Zhu B:
Study on anti-tumor effect of total glycosides from Radix paeoniae
rubra in S180 tumor-bearing mice. Afr J Tradit Complement Altern
Med. 10:580–585. 2013.PubMed/NCBI
|
|
10
|
Fang WK, Weng YJ, Chang MH, Lin CC, Chen
YS, Hsu HH, Tsai FJ, Tsai CH, Kuo WH, Lu CY and Huang CY:
Proliferative effects of chishao on injured peripheral neurons. Am
J Chin Med. 38:735–743. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu EH, Qi LW, Li B, Peng YB, Li P, Li CY
and Cao J: High-speed separation and characterization of major
constituents in Radix Paeoniae Rubra by fast high-performance
liquid chromatography coupled with diode-array detection and
time-of-flight mass spectrometry. Rapid Commun Mass Spectrom.
23:119–130. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li SL, Song JZ, Choi FF, Qiao CF, Zhou Y,
Han QB and Xu HX: Chemical profiling of Radix Paeoniae evaluated by
ultra-performance liquid
chromatography/photo-diode-array/quadrupole time-of-flight mass
spectrometry. J Pharm Biomed Anal. 49:253–266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koo YK, Kim JM, Koo JY, Kang SS, Bae K,
Kim YS, Chung JH and Yun-Choi HS: Platelet anti-aggregatory and
blood anti-coagulant effects of compounds isolated from Paeonia
lactiflora and Paeonia suffruticosa. Pharmazie.
65:624–628. 2010.PubMed/NCBI
|
|
14
|
Xu HY, Chen ZW and Wu YM: Antitumor
activity of total paeony glycoside against human chronic myelocytic
leukemia K562 cell lines in vitro and in vivo. Med Oncol.
29:1137–1147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Yang CL, Or TC, Chen G, Zhou J, Li
JC and Lau AS: Differential effects of Radix Paeoniae Rubra
(Chishao) on cytokine and chemokine expression inducible by
mycobacteria. Chin Med. 6:142011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ou TT, Wu CH, Hsu JD, Chyau CC, Lee HJ and
Wang CJ: Paeonia lactiflora Pall inhibits bladder cancer
growth involving phosphorylation of Chk2 in vitro and in vivo. J
Ethnopharmacol. 135:162–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parkin DM: The global burden of urinary
bladder cancer. Scand J Urol Nephrol Suppl. 42(s218): 12–20. 2008.
View Article : Google Scholar
|
|
18
|
Babjuk M, Oosterlinck W, Sylvester R,
Kaasinen E, Böhle A and Palou-Redorta J: European Association of
Urology (EAU): EAU guidelines on non-muscle-invasive urothelial
carcinoma of the bladder. Eur Urol. 54:303–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Manoharan M: Intravesical therapy for
urothelial carcinoma of the bladder. Indian J Urol. 27:252–261.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Witjes JA, Palou J, Soloway M, Lamm D,
Brausi M, Spermon JR, Persad R, Buckley R, Akaza H, Colombel M and
Bӧhle A: Clinical practice recommendations for the prevention and
management of intravesical therapy-associated adverse events. Euro
Urol. 7(Suppl): 667–674. 2008. View Article : Google Scholar
|
|
21
|
Gee J, Sabichi AL and Grossman HB:
Chemoprevention of superficial bladder cancer. Crit Rev Oncol
Hematol. 43:277–286. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chan E, Patel A, Heston W and Larchian W:
Mouse orthotopic models for bladder cancer research. BJU Int.
104:1286–1291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen CH, Shee JJ, Wu JY, Lin YW, Wu JD and
Liu YW: Combretastatin A-4 inhibits cell growth and metastasis in
bladder cancer cells and retards tumour growth in a murine
orthotopic bladder tumour model. Br J Pharmacol. 160:2008–2027.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu SY, Lee YR, Huang CC, Li YZ, Chang YS,
Yang CY, Wu JD and Liu YW: Curcumin-induced heme oxygenase-1
expression plays a negative role for its anti-cancer effect in
bladder cancers. Food Chem Toxicol. 50:3530–3536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu JY, Tsai KW, Li YZ, Chang YS, Lai YC,
Laio YH, Wu JD and Liu YW: Anti-bladder-tumor effect of baicalein
from Scutellaria baicalensis Georgi and its application in
vivo. Evid Based Complement Alternat Med. 2013:5797512013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li G, Seo CS, Lee KS, Kim HJ, Chang HW,
Jung JS, Song DK and Son JK: Protective constituents against sepsis
in mice from the root cortex of Paeonia suffruticosa. Arch
Pharm Res. 27:1123–1126. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hung JY, Yang CJ, Tsai YM, Huang HW and
Huang MS: Antiproliferative activity of paeoniflorin is through
cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway
in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol
Physiol. 35:141–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang L and Zhang S: Modulating Bcl-2
family proteins and caspase-3 in induction of apoptosis by
paeoniflorin in human cervical cancer cells. Phytother Res.
25:1551–1557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu S, Yang L, Tian R, Wang Z, Liu Z, Xie P
and Feng Q: Species differentiation and quality assessment of Radix
Paeoniae Rubra (Chi-shao) by means of high-performance liquid
chromatographic fingerprint. J Chromatogr A. 1216:2163–2168. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu M and Gu Z: Screening of bioactive
compounds from moutan cortex and their anti-inflammatory activities
in rat synoviocytes. Evid Based Complement Alternat Med. 6:57–63.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu S, Sun W, Wei W, Wang D, Jin J, Wu J,
Chen J, Wu H and Wang Q: Involvement of the prostaglandin E
receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
Anticancer Drugs. 24:140–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu H, Li W, Wang T, Shu Y and Liu P:
Paeoniflorin suppress NF-kappaB activation through modulation of I
kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human
gastric carcinoma cells. Biomed Pharmacother. 62:659–666. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fang S, Zhu W, Zhang Y, Shu Y and Liu P:
Paeoniflorin modulates multidrug resistance of a human gastric
cancer cell line via the inhibition of NF-κB activation. Mol Med
Rep. 5:351–356. 2012.PubMed/NCBI
|
|
34
|
Ou TT, Wang CJ, Lee YS, Wu CH and Lee HJ:
Gallic acid induces G2/M phase cell cycle arrest via regulating
14-3-3β release from Cdc25C and Chk2 activation in human bladder
transitional carcinoma cells. Mol Nutr Food Res. 54:1781–1790.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuo CL, Lai KC, Ma YS, Weng SW, Lin JP and
Chung JG: Gallic acid inhibits migration and invasion of SCC-4
human oral cancer cells through actions of NF-κB, Ras and matrix
metalloproteinase-2 and −9. Oncol Rep. 32:355–361. 2014.PubMed/NCBI
|
|
36
|
Liang W, Li X, Li Y, Li C, Gao B, Gan H,
Li S, Shen J, Kang J, Ding S, et al: Gallic acid induces apoptosis
and inhibits cell migration by upregulating miR-518b in SW1353
human chondrosarcoma cells. Int J Oncol. 44:91–98. 2014.PubMed/NCBI
|
|
37
|
Ho HH, Chang CS, Ho WC, Liao SY, Lin WL
and Wang CJ: Gallic acid inhibits gastric cancer cells metastasis
and invasive growth via increased expression of RhoB,
downregulation of AKT/small GTPase signals and inhibition of NF-κB
activity. Toxicol Appl Pharmacol. 266:76–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Verma S, Singh A and Mishra A: Gallic
acid: Molecular rival of cancer. Environ Toxicol Pharmacol.
35:473–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Raina K, Rajamanickam S, Deep G, Singh M,
Agarwal R and Agarwal C: Chemopreventive effects of oral gallic
acid feeding on tumor growth and progression in TRAMP mice. Mol
Cancer Ther. 7:1258–1267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee SH, Kim JK, Kim DW, Hwang HS, Eum WS,
Park J, Han KH, Oh JS and Choi SY: Antitumor activity of methyl
gallate by inhibition of focal adhesion formation and Akt
phosphorylation in glioma cells. Biochim Biophys Acta.
1830:4017–4029. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee H, Lee H, Kwon Y, Lee JH, Kim J, Shin
MK, Kim SH and Bae H: Methyl gallate exhibits potent antitumor
activities by inhibiting tumor infiltration of
CD4+CD25+ regulatory T cells. J Immunol.
185:6698–6705. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Che CT, Wang ZJ, Chow MSS and Lam CWK:
Herb-herb combination for therapeutic enhancement and advancement:
Theory, practice and future perspectives. Molecules. 18:5125–5141.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Barocas DA and Clark PE: Bladder cancer.
Curr Opin Oncol. 20:307–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
